W
Winfried März
Researcher at Heidelberg University
Publications - 398
Citations - 46505
Winfried März is an academic researcher from Heidelberg University. The author has contributed to research in topics: Vitamin D and neurology & Genome-wide association study. The author has an hindex of 74, co-authored 361 publications receiving 36423 citations. Previous affiliations of Winfried März include University of Ulm & University of Graz.
Papers
More filters
Journal ArticleDOI
Uric acid is predictive of cardiovascular mortality and sudden cardiac death in subjects referred for coronary angiography
Guenther Silbernagel,Michael Hoffmann,Tanja B. Grammer,Bernhard O. Boehm,Winfried März,Winfried März,Winfried März +6 more
TL;DR: High SUA independently indicates increased risk for cardiovascular and sudden cardiac death in subjects referred for coronary angiography, including cardiovascular risk factors and the severity of coronary atherosclerosis as covariates in the models.
Journal ArticleDOI
Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study
Irene Pusceddu,Wolfgang Herrmann,Marcus E. Kleber,Hubert Scharnagl,Michael M. Hoffmann,Brigitte M. Winklhofer-Roob,Winfried März,Winfried März,Winfried März,Markus Herrmann +9 more
TL;DR: Hyperhomocysteinemia and vitamin B6 deficiency correlate with increased mortality and might be explained by accelerated telomere shortening induced by oxidative stress and systemic inflammation in these circumstances.
Journal ArticleDOI
Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
Thomas Grenkowitz,Ursula Kassner,Marion Wühle-Demuth,Bastian Salewsky,Adrian Rosada,Tomasz Zemojtel,Werner Hopfenmüller,Berend Isermann,Katrin Borucki,Franz Heigl,Ulrich Laufs,Stephan Wagner,Marcus E. Kleber,Priska Binner,Winfried März,Elisabeth Steinhagen-Thiessen,Ilja Demuth +16 more
TL;DR: The frequency and the spectrum of FH causing mutations in Germany are investigated and this study further substantiates the mutation spectrum for FH in German patients and confirms the clinical and genetic heterogeneity of the disease.
Journal ArticleDOI
Beyond LDL-C lowering: distinct molecular sphingolipids are good indicators of proprotein convertase subtilisin/kexin type 9 (PCSK9) deficiency.
Minna Jänis,Kirill Tarasov,Hung Xuan Ta,Matti Suoniemi,Kim Ekroos,Reini Hurme,Terho Lehtimäki,Hannu Päivä,Marcus E. Kleber,Winfried März,Winfried März,Winfried März,Annik Prat,Nabil G. Seidah,Reijo Laaksonen +14 more
TL;DR: Plasma molecular lipid species may be utilized for characterizing novel compounds inhibiting PCSK9 and as sensitive efficacy markers of the PCSK 9 inhibition.
Journal ArticleDOI
Vitamin D and Cardiovascular Disease: An Updated Narrative Review
Armin Zittermann,Christian Trummer,Verena Theiler-Schwetz,Elisabeth Lerchbaum,Winfried März,Winfried März,Winfried März,Stefan Pilz +7 more
TL;DR: In this paper, the potential impact of vitamin D on the risk of cardiovascular disease (CVD) has been rigorously studied, and there is no strong evidence for beneficial vitamin D effects on CVD risk, either in the general population or in high-risk groups.